Previous 10 | Next 10 |
Study will assess the clinical utility and workflow benefits of physicians using images acquired by the Swoop® Portable MR Imaging® system to identify ARIA events in Alzheimer’s patients treated with amyloid-targeting therapy Hyperfine, Inc. (Nasdaq: HYPR), the grou...
2024-03-21 18:55:05 ET Hyperfine, Inc. (HYPR) Q4 2023 Earnings Conference Call March 21, 2024 4:30 p.m. ET Company Participants Marissa Bych - Gilmartin Group, Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrativ...
2024-03-21 16:15:10 ET More on Hyperfine Seeking Alpha’s Quant Rating on Hyperfine Historical earnings data for Hyperfine Financial information for Hyperfine Read the full article on Seeking Alpha For further details see: Hyperfine GAAP EPS...
GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced f...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
The Princess Royal was introduced to the first FDA-cleared portable MR brain imaging system being used to test the disparities in MR access in low- and medium-resource countries Hyperfine, Inc. (Nasdaq: HYPR), the developer of the first FDA-cleared portable magnetic resonance (MR) b...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system, today announced that it will report financial results for th...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system, today announced plans to present at the upcoming Oppenheim...
The collaboration kicked off at the 2024 All-Star game in Indianapolis Athletic Heart will use the Swoop® Portable MR Imaging® system to provide brain imaging Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imag...
Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field MR brain imaging to aid physicians in the diagnosis of acute ischemic stroke Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging wi...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...